Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_BI_2024
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_PH_2022.
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_PH_2024_NIPPLE
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_SAN_2024
        • R-TF-015-004 Clinical investigation plan LEGIT_COVIDX_EVCDAO_2022
        • R-TF-015-004 Clinical investigation plan LEGIT_MC_EVCDAO_2019
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.
        • R-TF-015-004 Clinical investigation plan Legit.Health_IDEI_2023.
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_BI_2024
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_O_2022
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_PH_2022
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024_NIPPLE
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_SAN_2024
        • R-TF-015-006 Clinical investigation report LEGIT_COVIDX_EVCDAO_2022
        • R-TF-015-006 Clinical investigation report LEGIT_MC_EVCDAO_2019
        • R-TF-015-006 Clinical investigation report Legit.Health_IDEI_2023
      • R-TF-015-008 Clinical development plan_2023_002
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • Procedures
  • Records
  • TF_Legit.Health_Plus
  • Clinical
  • Investigation
  • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.

R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.

Ethics committee approval

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003, JD-004
  • Approver: JD-001
Previous
R-TF-015-004 Clinical investigation plan LEGIT_MC_EVCDAO_2019
Next
R-TF-015-004 Clinical investigation plan Legit.Health_IDEI_2023.
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)